---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-015658"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T08:28:14.109268+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ReShape Lifesciences prices $6M public offering of 2.6M units at $2.33/unit

## Summary
- Gross proceeds ~$6M from offering of 2,575,107 units at $2.33/unit; closed Feb 18, 2025.
- Each unit consists of one common share (or pre-funded warrant) and one warrant to buy one share at $5.83, subject to stockholder approval.
- Warrants have reset mechanism (floor $1.25) and alternative cashless exercise (1.2x shares); expire after merger or 60 days post approval.
- Net proceeds for general corporate purposes, merger with Vyome, asset sale to Ninjour; up to 50% to prepay Ascent Partners note.
- Maxim Group LLC acted as sole placement agent with 7% cash fee and 128,755 placement agent warrants.

## SEC filing metadata
- accession: 0001104659-25-015658
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925015658/0001104659-25-015658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925015658/tm253570d16_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-015658
- JSON: https://secwatch.observer/filing/0001104659-25-015658.json
- Plain text: https://secwatch.observer/filing/0001104659-25-015658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.